| Dr George M Zaharias, MD | |
|
1010 1st St N, Suite 350, Alabaster, AL 35007-8608 | |
| (205) 664-9995 | |
| (205) 621-9327 |
| Full Name | Dr George M Zaharias |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 1010 1st St N, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124162433 | NPI | - | NPPES |
| 009965675 | Medicaid | AL | |
| 51000037 | Other | AL | BLUE CROSS BLUE SHIELD AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 15921 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Complete Women's Care Of Alabama, Pc | 1850352642 | 9 |
News Archive
In a medical breakthrough, English scientists have developed a so-called "universal" vaccine to influenza - one that protects against all strains of the potentially deadly illness. This would do away with the need for a new vaccine each flu season they say. Seasonal flu affects up to 20 percent of the population and kills an average of 24,600 people each year. This vaccine would act against swine flu as well assure researchers.
Keryx Biopharmaceuticals today announced the publication of an article in the May 12th Journal of the National Cancer Institute, entitled "In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine," demonstrating the single agent activity of KRX-0401 (perifosine) in neuroblastoma tumor preclinical models.
Not all breast cancers are the same. Different types can mean different prognoses for the patient, and a different kind of treatment may be adequate. But how to classify tumors? Are molecular classification methods reliable? Mohammad Ali Lavasani and Farid Moinfar from the Unit of Breast and Gynecologic Pathology at the Medical University of Graz, Austria give a critical review of the literature with focus on "basal-like" carcinoma.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.
› Verified 2 days ago
| Entity Name | Complete Women's Care Of Alabama, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770627929 PECOS PAC ID: 1850352642 Enrollment ID: O20041025000826 |
News Archive
In a medical breakthrough, English scientists have developed a so-called "universal" vaccine to influenza - one that protects against all strains of the potentially deadly illness. This would do away with the need for a new vaccine each flu season they say. Seasonal flu affects up to 20 percent of the population and kills an average of 24,600 people each year. This vaccine would act against swine flu as well assure researchers.
Keryx Biopharmaceuticals today announced the publication of an article in the May 12th Journal of the National Cancer Institute, entitled "In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine," demonstrating the single agent activity of KRX-0401 (perifosine) in neuroblastoma tumor preclinical models.
Not all breast cancers are the same. Different types can mean different prognoses for the patient, and a different kind of treatment may be adequate. But how to classify tumors? Are molecular classification methods reliable? Mohammad Ali Lavasani and Farid Moinfar from the Unit of Breast and Gynecologic Pathology at the Medical University of Graz, Austria give a critical review of the literature with focus on "basal-like" carcinoma.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George M Zaharias, MD 1010 1st St N, Suite 350, Alabaster, AL 35007-8608 Ph: (205) 664-9995 | Dr George M Zaharias, MD 1010 1st St N, Suite 350, Alabaster, AL 35007-8608 Ph: (205) 664-9995 |
News Archive
In a medical breakthrough, English scientists have developed a so-called "universal" vaccine to influenza - one that protects against all strains of the potentially deadly illness. This would do away with the need for a new vaccine each flu season they say. Seasonal flu affects up to 20 percent of the population and kills an average of 24,600 people each year. This vaccine would act against swine flu as well assure researchers.
Keryx Biopharmaceuticals today announced the publication of an article in the May 12th Journal of the National Cancer Institute, entitled "In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine," demonstrating the single agent activity of KRX-0401 (perifosine) in neuroblastoma tumor preclinical models.
Not all breast cancers are the same. Different types can mean different prognoses for the patient, and a different kind of treatment may be adequate. But how to classify tumors? Are molecular classification methods reliable? Mohammad Ali Lavasani and Farid Moinfar from the Unit of Breast and Gynecologic Pathology at the Medical University of Graz, Austria give a critical review of the literature with focus on "basal-like" carcinoma.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.
› Verified 2 days ago
Dr. David L Spangler, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 408 1st St N Ste 200, Alabaster, AL 35007 Phone: 205-664-9994 Fax: 205-621-9327 | |
James W. Belyeu, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 644 2nd St Ne, Suite 204, Alabaster, AL 35007 Phone: 205-664-0442 Fax: 205-620-4382 | |
Dr. Mackenzie Flynn Woodson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 408 1st St N Ste 200, Alabaster, AL 35007 Phone: 205-664-9995 Fax: 205-621-9327 | |
Dr. Jessica Lynn Rodriguez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 408 1st St N Ste 200, Alabaster, AL 35007 Phone: 205-664-9995 Fax: 205-621-9327 | |
Dr. Earl Malcolm Simmons Iii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1010 1st St N, Suite 350, Alabaster, AL 35007 Phone: 205-664-9995 Fax: 205-621-9327 | |
Dr. James L Head, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1010 1st St N, Suite 350, Alabaster, AL 35007 Phone: 205-664-9995 Fax: 205-621-9327 |